Otsuka (OTCMKTS:OTSKY) Shares Gap Up on Better-Than-Expected Earnings

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY)’s share price gapped up prior to trading on Monday after the company announced better than expected quarterly earnings. The stock had previously closed at $34.4080, but opened at $36.44. Otsuka shares last traded at $36.5050, with a volume of 8,919 shares traded.

The company reported $0.70 earnings per share for the quarter, beating analysts’ consensus estimates of $0.51 by $0.19. The business had revenue of $4.41 billion for the quarter, compared to analysts’ expectations of $3.95 billion. Otsuka had a net margin of 15.50% and a return on equity of 12.93%. Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS.

Otsuka Stock Up 6.1%

The firm’s fifty day moving average price is $34.15 and its 200-day moving average price is $33.55. The company has a debt-to-equity ratio of 0.05, a current ratio of 2.17 and a quick ratio of 1.67. The firm has a market capitalization of $39.21 billion, a P/E ratio of 14.66, a PEG ratio of 7.60 and a beta of -0.04.

About Otsuka

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.